2017. Rifampicin in cutaneous leishmaniasis - a therapeutic trial in Saudi Arabia. Journal of Pakistan Association of Dermatologists. 16, 1 (Jan. 2017), 4–9. DOI:https://doi.org/10.66344/jpad.v16i1.838.